Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shusaku Ishikawa"'
Publikováno v:
Clinical Ophthalmology, Vol 2009, Iss default, Pp 395-400 (2009)
Yoshimi Nakamura, Shusaku Ishikawa, Yuko Nakamura, Hiroshi Sakai, Ichiko Henzan, Shoichi SawaguchiDepartment of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, JapanPurpose: To investigate the efficacy of dorzolamide 1% (bid or
Externí odkaz:
https://doaj.org/article/a443baba7c184a2cb7f19947c8e4c7d1
Publikováno v:
Clinical Ophthalmology, Vol 2008, Iss Issue 4, Pp 703-708 (2008)
Shusaku Ishikawa1, Yoshimi Nakamura1, Yuko Nakamura1, Hiroshi Sakai1, Shoichi Sawaguchi1, Kazuo Terashima2, Makoto Kanno2, Hidetoshi Yamashita21Department of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; 2Department of
Externí odkaz:
https://doaj.org/article/161be59dc63f42bc94d7cc825734152e
Autor:
Rajesh S. Kumar, Hiroshi Sakai, Makoto Araie, Shusaku Ishikawa, Atsuo Tomidokoro, Shoichi Sawaguchi, Chiharu Uejyo, Aiko Iwase, I. Henzan, Yuko Nakamura
Publikováno v:
Acta ophthalmologicaReferences. 99(1)
PURPOSE To evaluate association of the van Herick (VH) grades with the ultrasound biomicroscopic (UBM) parameters, appositional irido-trabecular contact (A-ITC) and plateau iris (PI) in a randomly sampled population. METHODS A 10% random sample of al
Autor:
Hidetoshi Yamashita, Shoichi Sawaguchi, Hiroshi Sakai, Yuko Nakamura, Kazuo Terashima, Shusaku Ishikawa, Makoto Kanno, Yoshimi Nakamura
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Shusaku Ishikawa1, Yoshimi Nakamura1, Yuko Nakamura1, Hiroshi Sakai1, Shoichi Sawaguchi1, Kazuo Terashima2, Makoto Kanno2, Hidetoshi Yamashita21Department of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; 2Department of
Autor:
Hiroshi Sakai, Yuko Nakamura, Yoshimi Nakamura, Shusaku Ishikawa, Sayo Shinjyo, Shoichi Sawaguchi
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 21(6)
To compare the efficacy, adverse effects, and patient compliance of latanoprost monotherapy with unfixed combination therapy with 0.5% timolol maleate and 1% dorzolamide in the treatment of chronic primary angle-closure glaucoma (CACG), 36 Japanese p